Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome common barriers faced by lipid nanoparticle(“LNP”)-delivered therapies related to rapid liver ...
The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...
Health Ministry to amend Rule 89 of D&C Rules for better clarity: Gireesh Babu, New Delhi Friday, April 24, 2026, 08:00 Hrs [IST] The Union Health Ministry has issued a draft noti ...
Nanobiotix ( (NBTX)) has issued an update. On April 20, 2026, Nanobiotix reported new preclinical data for its Nanoprimer platform, presented at the American Association for Cancer Research annual ...
Next-Gen Biologics Lead Healthcare InnovationThe Biologic Therapeutic Drug Market has emerged as one of the most ...
Explore the contrasting acceptance of gene therapy and genetic crop modification, highlighting societal attitudes and ...
Objectives Over the last decade, a growing number of health interventions (eg, medical assistance in dying and mitochondrial ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today ...
Canada's AuX Labs has raised $4M in funding to scale up production of its precision-fermented dairy protein and bring ...
AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully CharacterizedVANCOUVER, British Columbia, April 22, ...
Preeclampsia is a serious pregnancy disorder, affecting nearly 10 millionwomen globally each year, and can strike without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results